SARAJEVO (Bosnia and Herzegovina), September 11 (SeeNews) – Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Tuesday its net profit almost doubled to 942,964 marka ($558,600/482,130 euro) in the first six months of 2018, from 488,044 marka a year earlier.
Operating income increased 19.9% to 63.4 million marka in the six months through June, while operating costs climbed 7.5% to 54.9 million marka, Bosnalijek said in a filing with the Sarajevo Stock Exchange.
In October 2016, Bosnia's Federation government sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital.
The Federation is one of the two autonomous entities that make up Bosnia and Herzegovina. The other one is the Serb Republic.
(1 euro=1.95583 Bosnian marka)